Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 2 × binimetinib × Other solid neoplasm × Clear all

Phase

Phase 1 3 Phase 1/2 2 Phase 4 1 Phase 2 1

Status

Active not recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Dermatologic 22 CNS 11 Gastrointestinal 9 Thoracic 7 Other hematologic neoplasm 5 Plasma cell 3 Gynecologic 3 Breast 3 Tumor-Agnostic 2 Lymphoid 2 Head & Neck 2 Sarcoma 1 Other solid neoplasm 1 Genitourinary 1

Conditions

Interventions

Cisplatin 42 Pemetrexed 31 Carboplatin 28 Nivolumab 21 pembrolizumab 19 Gemcitabine 19 atezolizumab 13 Etoposide 13 Injections 12 Ipilimumab 11 Cyclophosphamide 11 Radiotherapy 10 Oxaliplatin 10 Filgrastim 10 Docetaxel 10 Bevacizumab 10 tislelizumab 9 Vincristine 9 Specimen Handling 9 durvalumab 8 Paclitaxel 8 Capecitabine 8 tremelimumab 7 toripalimab 7 lenvatinib 7 Everolimus 7 spartalizumab 6 olaparib 6 niraparib 6 Vinorelbine 6

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT03839342 2025-02-03

BEAVER

University Health Network, Toronto

Phase 2 Active not recruiting

Other solid neoplasm

Solid Tumor

Data powered by HemOnc (CC BY 4.0) Colophon ⚡